Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 3
1965 1
1966 3
1967 3
1968 4
1969 3
1970 1
1971 4
1972 1
1973 2
1974 3
1976 1
1977 1
1978 5
1980 1
1981 2
1982 1
1983 1
1984 1
1986 1
1987 2
1988 1
1989 2
1990 1
1991 3
1993 1
1995 2
1997 3
1998 3
1999 2
2000 1
2001 1
2002 3
2003 1
2004 2
2005 1
2009 1
2010 1
2011 2
2012 1
2013 3
2014 2
2015 2
2016 3
2017 5
2018 5
2019 8
2020 5
2021 14
2022 10
2023 5
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

138 results

Results by year

Filters applied: . Clear all
Page 1
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM; PROMINENT Investigators. Das Pradhan A, et al. N Engl J Med. 2022 Nov 24;387(21):1923-1934. doi: 10.1056/NEJMoa2210645. Epub 2022 Nov 5. N Engl J Med. 2022. PMID: 36342113 Clinical Trial.
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes.
Gerstein HC, Sattar N, Rosenstock J, Ramasundarahettige C, Pratley R, Lopes RD, Lam CSP, Khurmi NS, Heenan L, Del Prato S, Dyal L, Branch K; AMPLITUDE-O Trial Investigators. Gerstein HC, et al. N Engl J Med. 2021 Sep 2;385(10):896-907. doi: 10.1056/NEJMoa2108269. Epub 2021 Jun 28. N Engl J Med. 2021. PMID: 34215025 Clinical Trial.
CONCLUSIONS: In this trial involving participants with type 2 diabetes who had either a history of cardiovascular disease or current kidney disease plus at least one other cardiovascular risk factor, the risk of cardiovascular events was lower among those who received weekly subc …
CONCLUSIONS: In this trial involving participants with type 2 diabetes who had either a history of cardiovascular disease or current kidney …
Intramolecular Re...O Nonvalent Interactions as a Stabilizer of the Polyoxorhenate(VII).
Volkov MA, Novikov AP, Borisova NE, Grigoriev MS, German KE. Volkov MA, et al. Inorg Chem. 2023 Aug 21;62(33):13485-13494. doi: 10.1021/acs.inorgchem.3c01863. Epub 2023 Aug 10. Inorg Chem. 2023. PMID: 37599582
For the first time, intramolecular interactions of the Re...O, Re...mu-O, and O...O are described (previously known were only intermolecular ones). ...The Hirshfeld surface analysis showed that the main contribution to intermolecular interactions is ma …
For the first time, intramolecular interactions of the Re...O, Re...mu-O, and O...O are described (previously kn …
Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries.
De Backer G, Jankowski P, Kotseva K, Mirrakhimov E, Reiner Ž, Rydén L, Tokgözoğlu L, Wood D, De Bacquer D; EUROASPIRE V collaborators; Writing Committee; Scientific Steering/ Executive Committee; Coordinating centre; Diabetes centre; Data management centre; Statistical analysis centre; Central laboratory; Study centres, organisations, investigators and other research personnel (National Co-ordinators in each country are indicated by asterisk. De Backer G, et al. Atherosclerosis. 2019 Jun;285:135-146. doi: 10.1016/j.atherosclerosis.2019.03.014. Epub 2019 Apr 24. Atherosclerosis. 2019. PMID: 31054483
Treatment of Multisystem Inflammatory Syndrome in Children.
McArdle AJ, Vito O, Patel H, Seaby EG, Shah P, Wilson C, Broderick C, Nijman R, Tremoulet AH, Munblit D, Ulloa-Gutierrez R, Carter MJ, De T, Hoggart C, Whittaker E, Herberg JA, Kaforou M, Cunnington AJ, Levin M; BATS Consortium. McArdle AJ, et al. N Engl J Med. 2021 Jul 1;385(1):11-22. doi: 10.1056/NEJMoa2102968. Epub 2021 Jun 16. N Engl J Med. 2021. PMID: 34133854 Free PMC article.
XUV-Initiated Dissociation Dynamics of Molecular Oxygen (O(2)).
Rebholz M, Ding T, Aufleger L, Hartmann M, Meyer K, Stooß V, Magunia A, Wachs D, Birk P, Mi Y, Borisova GD, da Costa Castanheira C, Rupprecht P, Magrakvelidze M, Thumm U, Roling S, Butz M, Zacharias H, Düsterer S, Treusch R, Brenner G, Ott C, Pfeifer T. Rebholz M, et al. J Phys Chem A. 2021 Dec 2;125(47):10138-10143. doi: 10.1021/acs.jpca.1c06033. Epub 2021 Nov 17. J Phys Chem A. 2021. PMID: 34788037 Free PMC article.
Using an XUV-pump/XUV-probe transient-absorption geometry with a split-and-delay unit, we observe the onset of electronic transitions in the O(2+) cation near 50 eV photon energy, marking the end of the progression from a molecule to two isolated atoms. ...
Using an XUV-pump/XUV-probe transient-absorption geometry with a split-and-delay unit, we observe the onset of electronic transitions in the …
Ethidium probing of the parallel double- and four-stranded structures formed by the telomeric DNA sequences dG(GT)4G and d(GT)5.
Beschetnova IA, Kaluzhny DN, Livshits MA, Shchyolkina AK, Borisova OF. Beschetnova IA, et al. J Biomol Struct Dyn. 2003 Jun;20(6):789-99. doi: 10.1080/07391102.2003.10506895. J Biomol Struct Dyn. 2003. PMID: 12744708
Oligonucleotides 3'-d(GT)(5)-(CH(2)CH(2)O)(3)-d(GT)(5)-3' (parGT), containing GT repeats present in the telomeric DNA from Saccharomyces cerevisiae, had been demonstrated to form bimolecular structure, GT-quadruplex (qGT) [O. ...The data conform to the model of Et a …
Oligonucleotides 3'-d(GT)(5)-(CH(2)CH(2)O)(3)-d(GT)(5)-3' (parGT), containing GT repeats present in the telomeric DNA from Saccharomy …
Transient coating of gamma-Fe(2)O(3) nanoparticles with glutamate for its delivery to and removal from brain nerve terminals.
Paliienko K, Pastukhov A, Babič M, Horák D, Vasylchenko O, Borisova T. Paliienko K, et al. Beilstein J Nanotechnol. 2020 Sep 10;11:1381-1393. doi: 10.3762/bjnano.11.122. eCollection 2020. Beilstein J Nanotechnol. 2020. PMID: 32974116 Free PMC article.
Some components of the incubation medium of nerve terminals, that is, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) and NaH(2)PO(4), decreased the ability of gamma-Fe(2)O(3) nanoparticles to form a glutamate biocoating by about 50% and 90%, respectively. ...Gl …
Some components of the incubation medium of nerve terminals, that is, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) and NaH(2)P …
A novel acid-tolerant beta-xylanase from Scytalidium candidum 3C for the synthesis of o-nitrophenyl xylooligosaccharides.
Eneyskaya EV, Bobrov KS, Kashina MV, Borisova AS, Kulminskaya AA. Eneyskaya EV, et al. J Basic Microbiol. 2020 Nov;60(11-12):971-982. doi: 10.1002/jobm.202000303. Epub 2020 Oct 25. J Basic Microbiol. 2020. PMID: 33103248
The kinetic parameters of ScXynA were determined in hydrolysis reactions with p-nitrophenyl-beta-d-cellobioside (pNP-beta-Cel) and p-nitrophenyl-beta-d-xylobioside (pNP-beta-Xyl(2) ), and k(cat) /K(m) was found to be 0.43 0.02 (s.mM)(-1) and 57 3 (s.mM)(-1) , respectively. In the …
The kinetic parameters of ScXynA were determined in hydrolysis reactions with p-nitrophenyl-beta-d-cellobioside (pNP-beta-Cel) and p-nitroph …
Time-resolving state-specific molecular dissociation with XUV broadband absorption spectroscopy.
Magunia A, Rebholz M, Appi E, Papadopoulou CC, Lindenblatt H, Trost F, Meister S, Ding T, Straub M, Borisova GD, Lee J, Jin R, von der Dellen A, Kaiser C, Braune M, Düsterer S, Ališauskas S, Lang T, Heyl C, Manschwetus B, Grunewald S, Frühling U, Tajalli A, Wahid AB, Silletti L, Calegari F, Mosel P, Morgner U, Kovacev M, Thumm U, Hartl I, Treusch R, Moshammer R, Ott C, Pfeifer T. Magunia A, et al. Sci Adv. 2023 Nov 24;9(47):eadk1482. doi: 10.1126/sciadv.adk1482. Epub 2023 Nov 22. Sci Adv. 2023. PMID: 37992169 Free PMC article.
Here, we combine a broadband XUV probe pulse from high-order harmonic generation with an FEL pump pulse to observe dissociation pathways leading to fragments in different quantum states. We temporally resolve the dissociation of a specific O(2)(+) state into two competing …
Here, we combine a broadband XUV probe pulse from high-order harmonic generation with an FEL pump pulse to observe dissociation pathways lea …
138 results